BCL-2/JH Rearrangements in Circulating B Cells of Healthy Blood Donors and Patients with Nonmalignant Diseases

Journal of Clinical Oncology

Volumn 14, Issue 4, 1996, Pages 1333-1344

  Dölken, Gottfried ^a   Illerhaus, Gerald ^b   Hirt, Carsten ^b   Mertelsmann, Roland ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD DONOR; CELL CULTURE; CHROMOSOME 14; CHROMOSOME 18; FEMALE; FOLLICULAR LYMPHOMA; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETICS; HUMAN; MALE; MIDDLE AGED; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; POLYMERASE CHAIN REACTION; B CELL LYMPHOMA; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 14; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN CELL; MALIGNANT TRANSFORMATION; MONONUCLEAR CELL; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; B-LYMPHOCYTES; BASE SEQUENCE; BLOOD DONORS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; GENE REARRANGEMENT; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

DNA FRAGMENT; IMMUNOGLOBULIN HEAVY CHAIN; PROTEIN BCL 2;

EID: 0029665393     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.4.1333     Document Type: Article

References (49)

1. Foulds L: The natural history of cancer. J Chronic Dis 8:2-37, 1958
2. Klein G, Klein E: Evolution of tumours and the impact of molecular oncology. Nature 315:190-195, 1985
3. Yunis JJ, Frizzera G, Oken MM, et al: Multiple recurrent genomic defects in follicular lymphoma, a possible model for cancer. N Engl J Med 316:79-84, 1987
4. Rowley JD: Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27:122-136, 1990
5. McKeithan TW: Molecular biology of non-Hodgkin's lymphomas. Semin Oncol 17:30-42, 1990
6. Nichols J, Nimer SD: Transcriptions factors, translocations, and leukemia. Blood 80:2953-2963, 1992
7. Tsujimoto Y, Gorham J, Cossman J, et al: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390-1393, 1985
8. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439-7443, 1985
9. Bakhshi A, Jensen, Goldman P, et al: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: Clustering around Jh on chromosome 14 and near a transcriptional unit on 18. Cell 41:899-906, 1985
10. Seto M, Jaeger U, Hockett RD, et al: Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123-131, 1988
11. Shima EA, Le Beau MM, McKeithan TW, et al: Gene encoding the alpha chain of the T cell receptor is moved immediately downstream of c-myc in a chromosomal 8;14 translocation in a cell line from a human T-cell leukemia. Proc Natl Acad Sci USA 83:3439-3443, 1986
12. McKeithan TW, Shima EA, Le Beau MM, et al: Molecular cloning of the breakpoint junction of a human chromosomal 8;14 translocation involving the T-cell receptor alpha-chain gene and sequences on the 3′ side of MYC. Proc Natl Acad Sci USA 83:6636-6648, 1986
13. Finver SN, Nishikura K, Finger LR, et al: Sequence analysis of the MYC oncogene involved in the t(8;14)(q24;q11) chromosome translocation in a human T-cell line indicates that putative regulatory elements are not altered. Proc Natl Acad Sci USA 85:3052-3056, 1988
14. Wyatt RT, Rudders RA, Zelenetz A, et al: BCL2 oncogene translocation is mediated by a chi-like consensus. J Exp Med 175:1575-1588, 1992
15. Levine EG, Arthur DC, Frizzera G, et al: There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphomas. Blood 66:1414-1422, 1985
16. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214-5218, 1986
17. Cleary ML, Galili N, Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315-320, 1986
18. Tsujimoto Y, Bashir MM, Givol I, et al: DNA rearrangements in human follicular lymphoma can involve the 5′ or the 3′ region of the bcl-2 gene. Proc Natl Acad Sci USA 84:1329-1331, 1987
19. Hockenbery D, Nunez G, Milliman C, et al: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334-336, 1990
20. Nunez G, London L, Hockenbery D, et al: Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602-3610, 1990
21. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulators of cell death. Blood 80:879-886, 1992
22. McDonnell TJ, Nunez G, Platt FM, et al: Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10:1901-1907, 1990
23. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254-256, 1991
24. Price CGA, Meerabux J, Murtagh S, et al: The significance of circulating cells carrying t(14;18) in long remission from follicular lymphoma. J Clin Oncol 9:1527-1532, 1991
25. Finke J, Slanina J, Lange W, et al: Persistence of circulating t(14;18)-positive cells in long-term remission after radiation therapy for localized-stage follicular lymphoma. J Clin Oncol 11:1668-1673, 1993
26. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271-2276, 1991
27. Aster JC, Kobayashi Y, Shiota M, et al: Detection of the t(14;18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. Am J Pathol 141:291-299, 1992
28. Limpens J, Stad R, de Vlaam C, et al: B-cells with the Iymphoma associated translocation t(14;18) are present in blood B-cells of normal individuals. Blood 80:258a. 1992 (suppl 1, abstr)
29. Liu Y, Hernandez AM, Shibata D, et al: BCL2 translocation frequency rises with age in humans. Proc Natl Acad Sci USA 91:8910-8914, 1994
30. Dyer MJS, Fischer P, Nacheva E, et al: A new human B-cell Non-Hodgkin's lymphoma cell line (Karpas 422) exhibiting both t(14;18) and t(4;11) chromosomal translocations. Blood 75:709-714, 1990
31. Stansfeld AG, Diebold J, Noel H, et al: Updated Kiel classification for lymphomas. Lancet 1:292-293, 1988
32. Kirby KS: A new method for the isolation of deoxyribonucleotide acids: Evidence on the nature of bonds between deoxyribonucleotide acid and protein. Biochem J 66:495-504, 1957
33. Crescenzi M, Seto M, Herzig GP, et al: Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 85:4869-4873, 1988
34. Ravetch JV, Siebenlist U, Korsmeyer S, et al: Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes. Cell 27:583-591, 1981
35. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19-28, 1986
36. Reed KC, Mann DA: Rapid transfer of DNA from agarose gels to nylon membranes. Nucleic Acids Res 13:7207-7221, 1985
37. Cortopassi GA, Arnheim N: Using the polymerase chain reaction to estimate mutation frequencies and rates in human cells. Mutat Res 277:239-249, 1992
38. Lee M-S, Chang K-S, Cabanillas F, et al: Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification. Science 237:175-178, 1987
39. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. Genomics 9:219-228, 1977
40. Ichihara Y, Matsuoka H, Kurosawa Y: Organization of human immunoglobulin heavy chain diversity gene loci. EMBO J 7:4141-4150, 1988
41. Cotter FE, Price C, Meerabux J, et al: Direct sequencing of 14q+ and 18q- chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma. Ann Oncol 2:93-97, 1991
42. Shibata D, Hu E, Weiss LM, et al: Detection of specific t(14;18) chromosomal translocations in fixed tissues. Hum Pathol 21:199-203, 1990
43. Pezzella F, Gatter KC, Mason DY: Detection of the 14;18 chromosomal translocation in paraffin-embedded lymphoma tissue. Lancet 1:779-780, 1989
44. Seite P, Hillion J, D'Agay M-F, et al: BCL2 gene activation and protein expression in follicular lymphoma: A report on 64 cases. Leukemia 7:410-417, 1993
45. Weiss LM, Warnke RA, Sklar J, et al: Molecular analysis of the t(14;18) chromosomal translocation in malignant lymphomas. N Engl J Med 317:1185-1189, 1987
46. Johnson PWM, Price CGA, Smith T, et al: Detection of cells bearing the t(14;18) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J Clin Oncol 12:798-805, 1994
47. LeBrun DP, Ngan B-Y, Weiss LM, et al: The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma. Blood 83:223-230, 1994
48. Uhr JW, Tucker T, May RD, et al: Cancer dormancy: Studies of the murine BCL1 lymphoma. Cancer Res 51:5045s-5053s, 1991 (suppl)
49. Yefenof E, Picker LJ, Scheuermann RH, et al: Induction of B cell dormancy by anti-idiotypic antibodies. Curr Opin in Immunol 5:740-744, 1993